LY 2828360

Drug Profile

LY 2828360

Alternative Names: Cannaboid receptor-2 agonist - Eli Lilly; LY2828360

Latest Information Update: 19 Apr 2012

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Eli Lilly
  • Class Non-opioid analgesics
  • Mechanism of Action Cannabinoid receptor CB2 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Musculoskeletal pain

Most Recent Events

  • 17 Jan 2012 Discontinued - Phase-II for Musculoskeletal pain in Denmark (PO)
  • 30 Sep 2011 Eli Lily completes a phase II trial in Musculoskeletal pain in Denmark (NCT01319929)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top